Professional Summary
Professional Overview
Scott Stubbe is an experienced pharmaceutical and biotechnology executive with a strong background in clinical operations. As the Vice President of Clinical Operations at Viking Therapeutics, Inc., he leads a team responsible for the efficient and effective execution of clinical trials for the company's drug development pipeline.
Experience Summary
Current Role
As the Vice President of Clinical Operations at Viking Therapeutics, Inc., Scott is responsible for overseeing all aspects of the company's clinical trial operations, including study design, project management, data management, and regulatory compliance. He has been instrumental in streamlining clinical processes, implementing industry-leading practices, and fostering a collaborative team environment to drive the successful advancement of Viking's therapeutic candidates.
Career Progression
Prior to his current role, Scott held several senior-level positions in clinical operations at prominent pharmaceutical and biotechnology companies, including ACADIA Pharmaceuticals Inc. and Arena Pharmaceuticals Inc. Throughout his career, he has demonstrated a strong track record of leading cross-functional teams, optimizing clinical trial workflows, and delivering measurable improvements in operational efficiency and study timelines.
Academic Background
Scott holds a Bachelor of Science degree in Biology from the University of California, San Diego, where he graduated with honors. His academic achievements and research experience have provided a solid foundation for his successful career in the pharmaceutical industry.
Areas of Expertise
Scott's areas of expertise include:
- Clinical trial management and operational excellence
- Regulatory compliance and quality assurance
- Project and program management
- Stakeholder engagement and cross-functional collaboration
- Strategic planning and decision-making
- Talent development and team leadership
Professional Impact
During his tenure at ACADIA Pharmaceuticals, Scott played a pivotal role in the successful execution of several pivotal clinical trials, contributing to the company's regulatory approvals and commercial success. His innovative approaches to clinical operations have been recognized by industry peers, and he has been invited to speak at various conferences and forums, sharing his insights and best practices with the broader pharmaceutical community.
Conclusion
With over 20 years of experience in the pharmaceutical industry, Scott Stubbe has established himself as a respected leader in clinical operations. His deep understanding of the drug development process, combined with his proven ability to drive operational excellence, make him a valuable asset to Viking Therapeutics as they continue to advance their innovative therapeutic pipeline.
